Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | POLR3B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | C17orf53 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | SFT2D3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | FCHO2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | TRIP10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | PCDHGA8 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | RP1-130H16.18 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | WFDC13 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
mRNA | MTMR9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |